Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.

Saved in:
Bibliographic Details
Title: Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.
Authors: Agarwal S; Department of Internal Medicine, Rosalind Franklin University of Medicine and Science Chicago Medical School, North Chicago, IL, USA., Agarwal SK; Department of Cardiology, Rashid hospital, Dubai, United Arab Emirates. skacardio@yahoo.com.
Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2021 Jun; Vol. 35 (3), pp. 427-440. Date of Electronic Publication: 2020 Sep 12.
Publication Type: Journal Article; Review
Journal Info: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7241
DOI:10.1007/s10557-020-07070-1